CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 2007; 57:326-340
doi: 10.3322/CA.57.6.326
© 2007 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sedjo, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sedjo, R. L.

A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015

Rebecca L. Sedjo, PhD, Tim Byers, MD, MPH, Ermilo Barrera, Jr., MD, Carmel Cohen, MD, Elizabeth T. H. Fontham, MPH, DrPH, Lisa A. Newman, MD, MPH, Carolyn D. Runowicz, MD, Alan G. Thorson, MD, Michael J. Thun, MD, MS, Elizabeth Ward, PhD, Richard C. Wender, MD, Harmon J. Eyre, MD on behalf of for the ACS Cancer Incidence & Mortality Ends Committee

Dr. Sedjo is Instructor, Department of Preventive Medicine, University of Colorado Health Sciences Center, Aurora, CO.
Dr. Byers is Professor, Department of Preventive Medicine and Biometrics; and Deputy Director, University of Colorado Cancer Center, Aurora, CO.
Dr. Barrera is Assistant Professor of Surgery, Feinberg School of Medicine, Northwestern University; and Head, Division of Surgery, Glenbrook Hospital, Evanston Northwestern Healthcare, Evanston, IL.
Dr. Cohen is Professor of Clinical Obstetrics and Gynecology, Columbia University, College of Physicians and Surgeons, Division of Gynecologic Oncology, New York, NY.
Dr. Fontham is Professor; and Dean, School of Public Health, LSU Health Sciences Center School of Public Health, New Orleans, LA.
Dr. Newman is Associate Professor; and Director, University of Michigan Breast Care Center, University of Michigan, Ann Arbor, MI.
Dr. Runowicz is Director, Carole and Ray Neag Comprehensive Cancer Center; Northeast Utilities Chair in Experimental Oncology; and Professor of Obstetrics and Gynecology, Division of Gynecologic Oncology, Neag Comprehensive Cancer Center, Farmington, CT.
Dr. Thorson is Clinical Associate Professor of Surgery, Creighton School of Medicine and the University of Nebraska College of Medicine; and Program Director, Section of Colon and Rectal Surgery, Creighton University, Omaha, NE.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Wender is President, American Cancer Society, Atlanta, GA; and Alumni Professor and Chair, Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA.
Dr. Eyre is Executive Vice President for Research and Medical Affairs; and Editor-in-Chief of CA: A Cancer Journal for Clinicians, American Cancer Society, Atlanta, GA.

This article is available online at http://CAonline.AmCancerSoc.org

In 1998, the American Cancer Society (ACS) set a challenge goal for the nation to reduce cancer incidence by 25% over the period between 1992 and 2015. This report examines the trends in cancer incidence between 1992 and 2004. Trends were calculated using data on incident malignant cancer cases from the Surveillance, Epidemiology, and End Results (SEER) Registry. Delay-adjusted incidence trends for all cancer sites; all cancer sites without prostate cancer included; all cancer sites stratified by gender, age, and race; and for 20 selected cancer sites are presented. Over the first half of the ACS challenge period, overall cancer incidence rates have declined by about 0.6% per year. The greatest overall declines were observed among men and among those aged 65 years and older. The pace of incidence reduction over the first half of the ACS challenge period was only half that necessary to put us on target to achieve the 25% cancer incidence reduction goal in 2015. New understandings of preventable factors are needed, and new efforts are also needed to better act on our current knowledge about how we can prevent cancer, especially by continuing to reduce tobacco use and beginning to reverse the epidemic of obesity.




This article has been cited by other articles:


Home page
 J Natl Compr Canc NetwHome page
D. G. Hewett, C. J. Kahi, and D. K. Rex
Does Colonoscopy Work?
J Natl Compr Canc Netw, January 1, 2010; 8(1): 67 - 77.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by American Cancer Society.